Sort
50,496 grants matching “lung cancer”
Targeting LCN2, a novel therapy for lung cancer
$696,569Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2025 · CA
Imaging Activated Macrophages in the Lungs
$696,557Timothy S Blackwell · Vanderbilt University Medical Center · R01 · FY2018 · HL
Therapeutic targeting MDSC-mediated immune suppression in cancer
$696,515Yulia Nefedova · Wistar Institute · R01 · FY2025 · CA
Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI
$696,450Iulian Constantin Ruset · Xemed, Llc · R01 · FY2022 · CA
Data Analysis and Modeling Core (DAM)
$696,413Jihyoun Jeon · University Of Michigan At Ann Arbor · U54 · FY2025 · CA
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
$696,404Virginia Chih-Yi Sun · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
GENES, DIET AND CARCINOGEN ACTIVATION IN SMOKERS
$696,398University Of Hawaii At Manoa · R01 · FY2001 · CA
Network Resource
$696,361Sook Wah Yee · University Of California, San Francisco · U19 · FY2013 · GM
Dissecting Yersinia Yop Targets in Neutrophils
$696,166Joan C. Mecsas · Tufts University Boston · R01 · FY2025 · AI
Phagocytosis--Pulmonary Alveolar Macrophages
$696,153Brigham And Women'S Hospital · R01 · FY2004 · HL
NOVEL RNA-BASED THERAPIES FOR LUNG CANCER
$696,149Beth Israel Deaconess Medical Center, Inc. · · FY2018 · Department of the Army
Harnessing digital health and equity informed multi-level implementation strategies to promote uptake of depression treatment in cancer settings: iCan DepCare
$696,140Nathalie Moise · Columbia University Health Sciences · R01 · FY2024 · CA
Fox COBRE Phase II Admin Core
$696,115Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
TIMP-2-mediated Tumor Cell Differentiation and Chemo-sensitization Therapy
$696,022William Stetler-Stevenson · Basic Sciences · Z01 · FY2007 · CA
The Environment and Epigenetic Gene Silencing in Cancer
$696,018Stephen B Baylin · Johns Hopkins University · R01 · FY2007 · ES
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
$695,920Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2020 · CA
Clinical Investigation of Signal Transduction Inhibitors
$695,684Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Molecular Mechanisms Regulating Endothelial Dysfunction
$695,580Hong Chen · Boston Children'S Hospital · R01 · FY2017 · HL
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$695,549Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2010 · CA
Taxi Health Access Interventions for Linkages and Lifestyle (HAILL)
$695,504Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2019 · NR
Identification of genomic drivers of brain metastases in lung adenocarcinoma
$695,450Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2020 · CA
Identification of genomic drivers of brain metastases in lung adenocarcinoma
$695,450Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2022 · CA
Identification of genomic drivers of brain metastases in lung adenocarcinoma
$695,450Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R01 · FY2021 · CA
Counseling older Americans to control hypertension (COACH)
$695,437Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2009 · MD
Theraputic targeting of pulmonary endothelial cells to inhibit pathological lung remodeling
$695,403Tanya Kalin · University Of Arizona · R01 · FY2025 · HL